Comparing mechanochemical endovenous ablation using Flebogrif with endovenous laser ablation in the treatment of primary great saphenous vein incompetence: protocol for a multicentre, open-label, non-inferiority, observer-blinded, randomised controlled trial (REBORN trial)

Comparing mechanochemical endovenous ablation using Flebogrif with endovenous laser ablation in the treatment of primary great saphenous vein incompetence: protocol for a multicentre, open-label, non-inferiority, observer-blinded, randomised controlled trial (REBORN trial)

Introduction Endovenous laser ablation (EVLA) is associated with an excellent outcome in the treatment of great saphenous vein (GSV) incompetence. However, the use of thermal ablation requires tumescent anaesthesia and is associated with a risk of thermal damage. Mechanochemical endovenous ablation...

Full description

Saved in:
Bibliographic Details
Main Authors: Çaĝdaş Ünlü, Sharon Oud, Tamana Alozai, Michiel A Schreve, Michael C Mooij, Clarissa J van Vlijmen
Format: Article
Language:English
Published: BMJ Publishing Group 2024-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/8/e087490.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/14/8/e087490.full

Similar Items